Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Meet Kevin Pricing Power... (PP)

Meet Kevin Pricing Power ETF
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:PP
DateTimeSourceHeadlineSymbolCompany
09/10/200818:03Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)AMEX:PPMeet Kevin Pricing Power ETF
06/10/200813:30MarketwiredPipex Pharmaceuticals to Present at the Maxim Group Growth Conference on October 7thAMEX:PPMeet Kevin Pricing Power ETF
19/09/200813:30MarketwiredPipex Pharmaceuticals' Oral TRIMESTA Phase IIa Clinical and Preclinical Findings Presented at World Congress on Treatment and ReAMEX:PPMeet Kevin Pricing Power ETF
29/08/200822:01Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Amended Annual Report (Small Business Issuers) (10KSB/A)AMEX:PPMeet Kevin Pricing Power ETF
19/08/200813:54MarketwiredPipex Pharmaceuticals Acquires Late-Stage Oral Phase II Candidate for Rheumatoid ArthritisAMEX:PPMeet Kevin Pricing Power ETF
19/08/200813:30MarketwiredPipex Pharmaceuticals, Inc. to Present at the RedChip Small Cap Investor Conference in New York CityAMEX:PPMeet Kevin Pricing Power ETF
14/08/200821:49Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Quarterly Report (10-Q)AMEX:PPMeet Kevin Pricing Power ETF
14/08/200821:18Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:PPMeet Kevin Pricing Power ETF
14/08/200818:39MarketwiredPipex Pharmaceuticals Announces Clinical Update and Second Quarter 2008 ResultsAMEX:PPMeet Kevin Pricing Power ETF
12/08/200813:27MarketwiredPipex Pharmaceuticals to Present at the Noble Financial Equity ConferenceAMEX:PPMeet Kevin Pricing Power ETF
15/07/200813:40Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Amended Statement of Beneficial Ownership (SC 13D/A)AMEX:PPMeet Kevin Pricing Power ETF
14/07/200823:45Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4)AMEX:PPMeet Kevin Pricing Power ETF
09/07/200819:48Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:PPMeet Kevin Pricing Power ETF
09/07/200813:38MarketwiredPipex Pharmaceuticals Announces Results of Eighty Patient, Six Month, Prospective, Randomized, Double-Blind Clinical Trial of OrAMEX:PPMeet Kevin Pricing Power ETF
08/07/200822:16Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:PPMeet Kevin Pricing Power ETF
08/07/200820:54MarketwiredPipex Pharmaceuticals to Host Conference Call at 10:15am ET Wednesday July 9th to Discuss Phase II Clinical Trial Results in DryAMEX:PPMeet Kevin Pricing Power ETF
08/07/200812:41MarketwiredPipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive OfficerAMEX:PPMeet Kevin Pricing Power ETF
20/05/200814:00MarketwiredPipex Pharmaceuticals Announces Issuance of Additional US Patent Covering CD4 Inhibitor MoleculesAMEX:PPMeet Kevin Pricing Power ETF
16/05/200815:59Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:PPMeet Kevin Pricing Power ETF
15/05/200822:13Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Quarterly Report (10-Q)AMEX:PPMeet Kevin Pricing Power ETF
15/05/200821:36MarketwiredPipex Pharmaceuticals Announces Clinical Update and First Quarter 2008 ResultsAMEX:PPMeet Kevin Pricing Power ETF
13/05/200814:05MarketwiredPipex Pharmaceuticals to Provide Clinical Update and Report First Quarter 2008 Results on Thursday, May 15AMEX:PPMeet Kevin Pricing Power ETF
12/05/200814:23MarketwiredPipex Pharmaceuticals Receives FDA Orphan Drug Designation for Oral TTM for Idiopathic Pulmonary Fibrosis (IPF)AMEX:PPMeet Kevin Pricing Power ETF
07/05/200814:00MarketwiredPipex Pharmaceuticals Announces Notice of Allowance of U.S. Patent for Oral TTM for Alzheimer's DiseaseAMEX:PPMeet Kevin Pricing Power ETF
02/05/200813:38Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:PPMeet Kevin Pricing Power ETF
29/04/200820:35Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Proxy Statement (definitive) (DEF 14A)AMEX:PPMeet Kevin Pricing Power ETF
21/04/200813:02MarketwiredPipex Pharmaceuticals' Oral Flupirtine Receives IND With FDA for Phase II Clinical Trial for FibromyalgiaAMEX:PPMeet Kevin Pricing Power ETF
18/04/200822:13Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)AMEX:PPMeet Kevin Pricing Power ETF
15/04/200816:12Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4)AMEX:PPMeet Kevin Pricing Power ETF
01/04/200818:49Edgar (US Regulatory)Pipex Pharmaceuticals, Inc. - Current report filing (8-K)AMEX:PPMeet Kevin Pricing Power ETF
 Showing the most relevant articles for your search:AMEX:PP